BioRealm

Executive Summary

BioRealm is a Los Angeles-based company offering integrated services in genomics, biostatistics, bioinformatics, and software development. With nearly 20 years of combined expertise, its transdisciplinary team delivers Bayesian analysis, predictive modeling, multi-omics integration, and statistical genetics to support precision medicine and drug discovery. Despite being founded in 2015, the company remains at an early stage ('Approved') with no disclosed funding or valuation, and limited public traction. However, its niche in combining AI/ML with genomics positions it well in a rapidly growing market. The company's low profile and lack of recent milestones suggest it may still be building its commercial foundation or seeking strategic partnerships to scale.

Upcoming Catalysts (preview)

• H2 2026Series A Funding Announcement30% success
• Q1 2027Major Pharmaceutical Partnership for Multi-Omics Analytics20% success
• Q3 2026Launch of AI-Driven Genomic Interpretation Platform25% success